2 treatment centers
No centers match
Try a different search term
2 SAMHSA-listed treatment centers in Livingston, Montana. Free, confidential help available 24/7 — most callers reach a licensed counselor in under 60 seconds.
Try a different search term
Livingston, Montana has 2 SAMHSA-verified addiction treatment centers offering a range of evidence-based programs. Substance use disorders affect millions of Americans, and access to quality, evidence-based treatment is critical to recovery.
Available programs in Livingston include, 2 outpatient programs, 1 dual diagnosis (co-occurring mental health) program. All listed facilities are sourced directly from the federal SAMHSA National Registry of Substance Abuse Treatment Services.
Most treatment centers in Livingston accept Medicaid, Medicare, and major private insurance plans including Aetna, Cigna, BlueCross BlueShield, and UnitedHealthcare. Under the Affordable Care Act (ACA) and the Mental Health Parity Act, insurance providers are required to cover substance use disorder treatment at the same level as other medical conditions. Call (319) 271-2077 for a free insurance verification — no obligation, completely confidential.
When selecting from the 2 treatment options in Livingston, consider: the type and severity of the substance use disorder, whether co-occurring mental health conditions require dual diagnosis treatment, your insurance coverage and financial situation, the distance from home and your support network, and the facility's accreditation and evidence-based approach. Our helpline is available 24/7 at (319) 271-2077 to help match you with the right program — free and confidential.
Free, confidential assistance matching you with the right program in Livingston.
Treatment centers in Livingston accept most major insurance plans including Medicaid, Medicare, Blue Cross Blue Shield, Aetna, Cigna, and UnitedHealthcare. Many facilities also offer sliding scale fees and payment plans. Call (319) 271-2077 to verify your coverage before admission.
Co-occurring mental-health conditions present in roughly half of Livingston addiction-treatment patients — anxiety disorders, depression, PTSD, bipolar disorder, attention disorders, and personality disorders interact with substance use in ways that demand integrated treatment. Sequential treatment models (substance use first, mental health later) generally produce worse outcomes than integrated approaches addressing both conditions simultaneously through coordinated clinical teams. Patients should ask Livingston providers explicitly about dual-diagnosis capacity during admissions consultation.
The addiction-treatment landscape in Livingston, Montana, reflects the broader epidemiology of substance use in the region: alcohol use disorder remains the most prevalent diagnosis at treatment intake nationally, opioid use disorder presents the highest overdose mortality, stimulant use disorder is increasingly common (cocaine and methamphetamine), and polysubstance use is the rule rather than the exception. Livingston providers structure programs to address this diversity — most treat the full range of substance-use disorders within an integrated clinical framework rather than maintaining substance-specific tracks.
Partial hospitalization (PHP) and intensive outpatient (IOP) programs in Livingston bridge residential and standard outpatient care. PHP typically runs 6 hours daily, 5 days/week, with patients returning home in the evenings — useful for patients with stable home environments who don't require 24-hour structure but need more support than weekly counseling provides. IOP runs 3-4 hours daily, 3-5 days/week, often in evening sessions compatible with continued employment. Both serve as effective step-downs from residential treatment.
Federal parity protections extend beyond just coverage existence to specific plan design elements: prior authorization burden, treatment day limits, financial requirements, and non-quantitative treatment limits must all be comparable between substance-use and medical/surgical benefits. Livingston patients encountering insurer practices that appear to discriminate against addiction-treatment access can file complaints with the Montana Department of Insurance, the U.S. Department of Labor (for ERISA plans), or the federal Center for Consumer Information and Insurance Oversight.
The first 90 days post-discharge are the highest-relapse-risk window for Livingston patients leaving residential treatment — multiple studies place 60-70% of relapses within this window. Structured continuity matters: same-team outpatient continuity, scheduled check-ins, structured-day expectations, and mutual-support engagement reduce 90-day relapse risk substantially compared to discharge-and-good-luck approaches. Programs that build this continuity into their model report measurably better outcomes than those treating discharge as the program endpoint.
Patients with co-occurring physical health conditions arriving at Livingston treatment programs require integrated medical management: medication continuity for chronic conditions (diabetes, hypertension, cardiac, respiratory), coordination with the patient's primary care provider, hepatitis C screening (with cure-rate treatment available through the program or referral), HIV testing where indicated, and management of pregnancy if applicable. Comprehensive intake protocols at quality Livingston facilities screen for these conditions on admission.
Family members of Livingston patients in active addiction can access support through Al-Anon, Nar-Anon, SMART Recovery Family & Friends, and Community Reinforcement and Family Training (CRAFT). CRAFT specifically teaches evidence-based techniques for engaging a reluctant family member into treatment — research shows approximately 70% of CRAFT participants successfully engage their loved one into treatment within 3-6 months, substantially higher than traditional intervention approaches.